000174736 000__ 01321fam\a2200313\a\4500
000174736 001__ 174736
000174736 005__ 20220217103530.0
000174736 008__ 880202s1988\\\\dcua\\\\\b\\\f00010\eng\d
000174736 035__ $$9(IS)TVF3347
000174736 035__ $$9AAU3039SI
000174736 035__ $$a174736
000174736 040__ $$aGPO$$cGPO
000174736 043__ $$an-us---
000174736 074__ $$a1019-A, 1019-B (microfiche)
000174736 0860_ $$aY 4.En 2/3:100-46
000174736 088__ $$aSerial no. 100-46 (United States. Congress. House. Committee on Energy and Commerce)
000174736 099__ $$aY 4.En 2/3:100-46
000174736 1101_ $$aUnited States.$$bCongress.$$bHouse.$$bCommittee on Energy and Commerce.$$bSubcommittee on Oversight and Investigations.
000174736 24510 $$aFDA regulation of ribavirin :$$bhearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundredth Congress, first session, May 28, 1987.
000174736 260__ $$aWashington :$$bU.S. G.P.O. :$$bFor sale by the Supt. of Docs., Congressional Sales Office, U.S. G.P.O.,$$c1988.
000174736 300__ $$aiii, 277 p. :$$bill. ;$$c24 cm.
000174736 500__ $$aDistributed to some depository libraries in microfiche.
000174736 500__ $$aShipping list no.: 88-47-P.
000174736 500__ $$a"Serial no. 100-46."
000174736 504__ $$aBibliography: p. 59-61.
000174736 650_0 $$aRibavirin.
000174736 650_0 $$aAntiviral agents.
000174736 650_0 $$aVirus diseases$$xChemotherapy.
000174736 85230 $$bdfich$$hY 4.EN 2/3:$$i100-46
000174736 909CO $$ooai:library.usi.edu:174736$$pGLOBAL_SET
000174736 948__ $$ac:jk
000174736 980__ $$aBIB
000174736 980__ $$aGOV RESOURCE